GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Tissue Procurement Facility

$2,678
Amy Patrice Skubitz · University Of Minnesota · P30 · FY2012 · CA

Tumor Biology & Progression

$2,678
James B. McCarthy · University Of Minnesota · P30 · FY2012 · CA

Integrated Small Animal Imaging Research Resource

$2,621
Chin-Tu Chen · University Of Chicago · P30 · FY2018 · CA

Genomics Core Facility

$2,552
Michael D Topal · Univ Of North Carolina Chapel Hill · P30 · FY2012 · CA

Tumor Biology Research Program

$2,510
Anil K Rustgi · University Of Pennsylvania · P30 · FY2018 · CA

Cancer Therapeutics Research Program

$2,510
Ravi K Amaravadi · University Of Pennsylvania · P30 · FY2018 · CA

The role of sympathetic nerve associated macrophages during pancreatic adenocarcinoma progression

$2,500
Jonathan Robert Weitz · University Of California, San Diego · F32 · FY2024 · CA

Defining and Targeting Malic Enzyme Dependence in Pancreatic Cancer

$2,500
Mengrou Shan · University Of Michigan At Ann Arbor · F32 · FY2023 · CA

Precision whole-body imaging of pancreatic cancer senescence with ImmunoPET

$2,500
Edwin Charles Pratt · Sloan-Kettering Inst Can Research · F32 · FY2023 · CA

Elucidating fibroblast/immune crosstalk and plasticity in pancreatic ductal adenocarcinoma

$2,500
Jennifer Susan Thalappillil · State University New York Stony Brook · F31 · FY2022 · CA

Interpreting limits to nanoparticle delivery in high-stroma low-perfusion tumors

$2,500
Stewart Russell · Dartmouth College · R03 · FY2017 · CA

HUMAN MESOTRYPSIN S195A - COMPLEX WITH APPI - CRYSTAL SCREEN CONDITION #33

$2,433
Evette S Radisky · Brookhaven Science Assoc-Brookhaven Lab · P41 · FY2010 · RR

Community Outreach and Engagement

$2,399
Ken A. Resnicow · University Of Michigan At Ann Arbor · P30 · FY2018 · CA

Structural Biology Shared Facility

$2,265
Lawrence J Delucas · University Of Alabama At Birmingham · P30 · FY2018 · CA

01 Inflammation, Immunology and Immunotherapeutics Program

$2,264
Donald J Buchsbaum · University Of Alabama At Birmingham · P30 · FY2018 · CA

PHASE IIA TRIAL TESTING ERLOTINIB AS AN INTERVENTION AGAINST INTRADUCTAL PANCREA

$2,264
Steven Monroe Lipkin · University Of California, San Diego · M01 · FY2009 · RR

Understanding cell intrinsic and context dependent metabolic adaptations of cancer cell

$2,212
Laura Victoria Danai · Massachusetts Institute Of Technology · F32 · FY2017 · CA

Tumor Biology Research Program

$2,143
Anil K Rustgi · University Of Pennsylvania · P30 · FY2018 · CA

Cancer Therapeutics Research Program

$2,143
Ravi K Amaravadi · University Of Pennsylvania · P30 · FY2018 · CA

Biostatistics and Bioinformatics Core

$2,137
Robert H Vonderheide · University Of Pennsylvania · P30 · FY2022 · CA

Genomic Analysis Core

$2,136
Tapan Ganguly · University Of Pennsylvania · P30 · FY2022 · CA

Program Integration and Management

$2,096
Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2016 · CA

Antibody targeting of ADAM8 for treatment of triple-negative breast cancer

$2,084
Gail E Sonenshein · Adecto Pharmaceuticals, Inc. · R44 · FY2019 · CA

First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer

$2,084
Alexander B Sigalov · Signablok, Inc. · R43 · FY2019 · CA

Implantable iontophoresis chemotherapy delivery device for direct infusion of gemcitabine into pancreatic adenocarcinoma: Device development and First-in-Human clinical trial

$2,084
William Andrew Daunch · Focal Medical, Inc. · R44 · FY2019 · CA